MedTrace Logo

Breast Stimulation vs. Low Dose Oxytocin Augmentation for Labor Induction

NCT05510310 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-08-22

No results posted yet for this study

Summary

To find the preferred method of labor induction (birth augmentation) for women with a history of one prior cesarean section scar and in grandmultiparas, the difference in time interval from augmentation to delivery will be measured between breast stimulation vs. low-dose oxytocin administration in this prospective single-center randomized controlled trial.

Conditions

  • Labor Onset and Length Abnormalities
  • Uterine Rupture
  • Birth; Induced

Interventions

PROCEDURE

Breast stimulation

By breast pump

BIOLOGICAL

Oxytocin

Oxytocin will be administered intravenously and titrated

Sponsors & Collaborators

  • Western Galilee Hospital-Nahariya

    lead OTHER_GOV

Principal Investigators

  • Maya Wolf, MD · Galilee Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2024-10-31
Completion
2025-04-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05510310 on ClinicalTrials.gov